CytomX Therapeutics, Inc. (CTMX)
3.91
-0.22
(-5.33%)
USD |
NASDAQ |
May 07, 14:08
CytomX Therapeutics Total Assets (Quarterly) : 152.50M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Johnson & Johnson | 200.89B |
| Rigel Pharmaceuticals, Inc. | 504.61M |
| Ovid Therapeutics, Inc. | 150.93M |
| Olema Pharmaceuticals, Inc. | 677.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.49M |
| Shareholders Equity (Quarterly) | 99.01M |
| Debt to Equity Ratio | 0.0428 |
| Current Ratio | 3.087 |
| Net Debt Paydown Yield | 0.18% |